当前位置: X-MOL 学术Drug. Discov. Today › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The signaling interplay of GSK-3β in myocardial disorders.
Drug Discovery Today ( IF 6.5 ) Pub Date : 2020-01-31 , DOI: 10.1016/j.drudis.2020.01.017
Arun K Sharma 1 , Punniyakoti V Thanikachalam 2 , Saurabh Bhatia 3
Affiliation  

Glycogen synthase kinase-3 (GSK-3) regulates numerous signaling transductions and pathological states, from cell growth, inflammation, apoptosis, and heart failure to cancer. Recent studies have validated the feasibility of targeting GSK-3β for its therapeutic potential to maintain myocardial homeostasis. Herein, we review the multifactorial roles of GSK-3β in cardiac abnormalities, focusing primarily on recent investigations into myocardial survival. In addition, we discuss the cardioprotective potential of divergent GSK-3β inhibitors. Finally, we also highlight crosstalk between the various mechanisms underlying abnormal myocardial functions in which GSK-3β is involved.

中文翻译:

GSK-3β在心肌疾病中的信号相互作用。

糖原合酶激酶3(GSK-3)调节多种信号转导和病理状态,从细胞生长,炎症,凋亡,心力衰竭到癌症。最近的研究已经证实了针对GSK-3β维持心肌动态平衡的治疗潜力的可行性。本文中,我们综述了GSK-3β在心脏异常中的多因素作用,主要侧重于对心肌存活的最新研究。此外,我们讨论了不同的GSK-3β抑制剂的心脏保护潜力。最后,我们还强调了涉​​及GSK-3β的异常心肌功能的各种机制之间的串扰。
更新日期:2020-01-31
down
wechat
bug